Bicara Therapeutics Inc. (BCAX)
NASDAQ: BCAX · Real-Time Price · USD
16.40
+0.52 (3.27%)
Oct 30, 2025, 1:13 PM EDT - Market open

Bicara Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22
896948--
Enterprise Value
433428--
Last Close Price
15.8817.42--
PB Ratio
1.991.93--
P/TBV Ratio
1.991.93--
Debt / Equity Ratio
0.010.000.00-
Quick Ratio
25.3427.2215.280.17
Current Ratio
25.8027.9315.320.21
Return on Equity (ROE)
-32.71%-19.14%-51.67%-
Return on Assets (ROA)
-22.85%-13.84%-20.72%-
Return on Capital (ROIC)
-24.01%-14.47%-24.70%-
Earnings Yield
-11.84%-7.17%--
FCF Yield
-11.65%-7.89%--
Buyback Yield / Dilution
-6191.81%-2796.96%-35.20%-
Updated Aug 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q